Search Results - "Tamaoka, A"

Nationwide survey on cerebral amyloid angiopathy in Japan by Sakai, K., Ueda, M., Fukushima, W., Tamaoka, A., Shoji, M., Ando, Y., Yamada, M.

“…Background and purpose A nationwide survey was conducted to understand the epidemiology of cerebral amyloid angiopathy‐related intracerebral hemorrhage…”
Get full text

Detection of elevated levels of α-synuclein oligomers in CSF from patients with Parkinson disease by TOKUDA, T, QURESHI, M. M, ARDAH, M. T, VARGHESE, S, SHEHAB, S. A. S, KASAI, T, ISHIGAMI, N, TAMAOKA, A, NAKAGAWA, M, EL-AGNAF, O. M. A

“…To date, there is no accepted clinical diagnostic test for Parkinson disease (PD) that is based on biochemical analysis of blood or CSF. The discovery of…”
Get full text

Decreased regional cerebral blood flow in patients with diphenylarsinic acid intoxication by Ishii, K., Nemoto, K., Iwasaki, N., Takeda, T., Masuda, T., Shibata, Y., Tamaoka, A.

“…Background and purpose Diphenylarsinic acid (DPAA) intoxication caused by drinking contaminated well water was found in Kamisu, Japan. The symptoms indicated…”
Get full text

Mumps virus encephalitis with symmetric claustrum lesions by Ishii, K, Tsuji, H, Tamaoka, A

Get full text

The effect of antioxidants in muscle regeneration process by Ishii, A, Yoshida, M, Ohkoshi, N, Tamaoka, A

Get full text

Clinical features of non-hypertensive lobar intracerebral hemorrhage related to cerebral amyloid angiopathy by Hirohata, M., Yoshita, M., Ishida, C., Ikeda, S. I., Tamaoka, A., Kuzuhara, S., Shoji, M., Ando, Y., Tokuda, T., Yamada, M.

“…Background and purpose:  The present study aims to clarify the clinical features of non‐hypertensive cerebral amyloid angiopathy‐related lobar intracerebral…”
Get full text

Sequential imaging analysis using MIBG scintigraphy revealed progressive degeneration of cardiac sympathetic nerve in Parkinson's disease by Watanabe, M., Takeda, T., Nakamagoe, K., Tamaoka, A.

“…Background:  Metaiodobenzylguanidine (MIBG) cardiac scintigraphy was used to differentiate Parkinson’s disease (PD) with Lewy body pathology from other…”
Get full text

Antioxidants improve muscle degeneration process by Ishii, A, Yoshida, M, Ueno, H, Kokubo, K, Ohkoshi, N, Tamaoka, A

Get full text

P.19.8 The effect of water-soluble fullerene with different number of hydroxyl groups in muscle regeneration process of experimental murine skeletal muscle by Ishii, A, Ohkoshi, N, Yoshida, M, Tamaoka, A

“…Muscular dystrophy is a hereditary disease, which cause severe muscle weakness and atrophy in clinically, and skeletal muscle degeneration and necrosis in…”
Get full text

G.P.204 by Ishii, A, Yoshida, M, Ohkoshi, N, Ueno, H, Kokubo, K, Tamaoka, A

“…Muscular dystrophy is a hereditary disease, which cause severe muscle weakness and atrophy in clinically, and skeletal muscle degeneration and necrosis in…”
Get full text

G.P.130 The effect of water-soluble fullerene in muscle regeneration process of experimental murine skeletal muscle by Ishii, A, Ohkoshi, N, Tamaoka, A

“…Abstract Muscular dystrophy is a hereditary disease, which causes severe muscle weakness and atrophy clinically, and skeletal muscle degeneration and necrosis…”
Get full text

Study of vestibular dysfunction in frontotemporal lobar degeneration by Nakamagoe, K, Fujimiya, M, Koganezawa, T, Shimizu, K, Fujizuka, N, Tamaoka, A

Get full text

A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer’s Disease by Senda, Michio, Ishii, K., Ito, K., Ikeuchi, T., Matsuda, H., Iwatsubo, T., Iwata, A., Ihara, R., Suzuki, K., Kasuga, K., Ikari, Y., Niimi, Y., Arai, H., Tamaoka, A., Arahata, Y., Itoh, Y., Tachibana, H., Ichimiya, Y., Washizuka, S., Odawara, T., Ishii, K., Ono, K., Yokota, T., Nakanishi, A., Matsubara, E., Mori, H., Shimada, H.

“…Background PET (positron emission tomography) and CSF (cerebrospinal fluid) provide the “ATN” (Amyloid, Tau, Neurodegeneration) classification and play an…”
Get full text

DISCORDANT CLINICOPATHOLOGIC PHENOTYPES IN A JAPANESE KINDRED OF FATAL FAMILIAL INSOMNIA by SAITOH, Y, OGAWA, M, NAITO, Y, KOMATSUZAKI, Y, TAGAYA, H, ARIMA, K, TAMAOKA, A, KITAMOTO, T, MURATA, M

Get full text

P3.33 The expression of amphiphysin-2 during skeletal muscle regeneration by Ishii, A, Ohkoshi, N, Tamaoka, A

Get full text

Randomized placebo‐controlled trial of zonisamide in patients with Parkinson's disease by Murata, Miho, Hasegawa, Kazuko, Kanazawa, Ichiro, Shirakura, Kenji, Kochi, Kenji, Shimazu, Rieko, Kimura, T, Yoshida, K, Abe, T, Kurita, K, Yoshizawa, K, Tamaoka, A, Nakano, I, Shimizu, T, Hattori, N, Mizusawa, H, Kuno, S, Yokochi, F, Hirabayashi, K, Horiuchi, E, Kawashima, N, Koike, R, Ishikawa, A, Kuriyama, M, Mizoguchi, K, Mitake, S, Washimi, Y, Tatsuoka, Y, Fujimura, H, Toda, K, Kondo, T, Nakashima, K, Nomoto, M, Uozumi, T, Sato, A, Matsuo, H, Tsuruta, K

“…Background We previously showed that zonisamide significantly improved parkinsonian symptoms by a multicenter, double‐blind clinical trial. Aim To confirm the…”
Get full text

P2.47 A polymyositis patient with anti-signal recognition particle (SRP) antibody refractory to corticosteroid treatment by Shioya, A, Takuma, H, Ishii, A, Tamaoka, A

Get full text

FP52-FR-02 Abnormal ocular movements after organoarsenic poisoning by Nakamagoe, K, Ishii, K, Tamaoka, A

Get full text

P4.64 Clinical experience with l -arginine treatment in MELAS syndrome by Ishii, A, Shioya, A, Hosaka, A, Ohkoshi, N, Nakamagoe, K, Tamaoka, A

Get full text

Drug interaction of tizanidine and ciprofloxacin: Case report by Momo, Kenji, Homma, Masato, Kohda, Yukinao, Ohkoshi, Norio, Yoshizawa, Toshihiro, Tamaoka, Akira

Get full text